These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 17521671

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Insights into the molecular pathogenesis of progression in multiple sclerosis: potential implications for future therapies.
    Imitola J, Chitnis T, Khoury SJ.
    Arch Neurol; 2006 Jan; 63(1):25-33. PubMed ID: 16401734
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Progressive multiple sclerosis: characteristics and management.
    Hawker K.
    Neurol Clin; 2011 May; 29(2):423-34. PubMed ID: 21439451
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH, Zozulya AL, Weidenfeller C, Metz I, Buck D, Toyka KV, Brück W, Wiendl H.
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Vitamin D as an immune modulator in multiple sclerosis, a review.
    Smolders J, Damoiseaux J, Menheere P, Hupperts R.
    J Neuroimmunol; 2008 Feb; 194(1-2):7-17. PubMed ID: 18177949
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Multiple sclerosis: is there neurodegeneration independent from inflammation?
    Lassmann H.
    J Neurol Sci; 2007 Aug 15; 259(1-2):3-6. PubMed ID: 17367814
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Future research directions in multiple sclerosis therapies.
    Greenberg BM, Calabresi PA.
    Semin Neurol; 2008 Feb 15; 28(1):121-7. PubMed ID: 18256992
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models.
    Murta V, Ferrari CC.
    Mol Cell Neurosci; 2013 Mar 15; 53():6-13. PubMed ID: 22771835
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Multifaceted aspects of inflammation in multiple sclerosis: the role of microglia.
    Muzio L, Martino G, Furlan R.
    J Neuroimmunol; 2007 Nov 15; 191(1-2):39-44. PubMed ID: 17936915
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.